MHE July 2020

August 03, 2020

Content of this article was sponsored by Arbor Pharmaceuticals, LLC. Copyright 2020. This Managed Healthcare Executive® publication provides key information regarding a review by Faraone, et al, which was originally published in the Journal of the American Academy of Child & Adolescent Psychiatry (doi: 10.1016/j.jaac.2019.06.012). The authors of the original review are Stephen V. Faraone, PhD; Anthony L. Rostain, MD; C. Brendan Montano, MD; Oren Mason, MD; Kevin M. Antshel, PhD; Jeffrey H. Newcorn, MD. Please consult the full published review for complete information.

August 01, 2020

COVID-19 spotlights the threat that cardiovascular disease poses to Americans; new technology may help address risk factors at the population health level.

July 31, 2020

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Third of three parts. See more in our Surveys tab.

July 31, 2020

Potential agents to battle inflammation and other processes move through development pipeline.

July 30, 2020

Advocates say a number of regulatory changes could help bring more of these products on to the market.

July 30, 2020

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Second of three parts. See more in our Surveys tab.

July 29, 2020

Underrepresentation of blacks in clinical trials is garnering special attention.

July 28, 2020

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. First of three parts. See more in our Surveys tab.

July 27, 2020

Senior Vice President and Chief Pharmacy Officer for Optum Rx and member of the Managed Healthcare Executive® Editorial Advisory Board, David Calabrese, provides his commentary on the future of pharmacy care services after the coronavirus pandemic.

July 27, 2020

Where some see bloat and trendiness, others see nimbleness and responsiveness.

July 25, 2020

Practice Fusion case spotlights how technology can be corrupted by commercial interests.

July 24, 2020

Companies are using rewards and ‘gamification’ to encourage patients to take their pills as prescribed.

July 23, 2020

Three healthcare organizations provide models for managing the disease and keeping a close eye on the bottom line.